Genentech BioOncology is leading the fight against cancer and has over 40 molecules in the pipeline.
Visit this comprehensive page to explore our robust oncology pipeline and find additional information on early and late-stage developments.
Explore the Met signaling pathway, which is dysregulated in many malignancies.
This section provides an in depth look at Met and it’s potential as a biomarker in the treatment of cancer.
Access educational resources about Glycoengineering in Research B-cell.
Learn more about the importance of PD-L1 and its relationship to cancer.
© 2011 Genentech USA, Inc. All rights reserved